Results 201 to 210 of about 9,905,323 (311)

Incidence and disease course of polymyalgia rheumatica during two decades: a nationwide study across healthcare sectors in Denmark

open access: yesArthritis &Rheumatology, Accepted Article.
Objective A new algorithm enables the identification of patients with polymyalgia rheumatica (PMR) across healthcare sectors in Denmark. We estimated annual incidence rates from 2003 to 2024 and described the disease course, including the occurrence of late‐onset GCA and prednisolone (PDN) treatment. Methods A Danish nationwide, population‐based cohort
Agnete O Donskov   +4 more
wiley   +1 more source

Dose-extending placebo effect in a rat model of buprenorphine maintenance treatment. [PDF]

open access: yesPsychopharmacology (Berl)
Pitts KM   +4 more
europepmc   +1 more source

Effects of Cannabidiol‐Rich Cannabis Oil on Facial Expression Recognition and Theory of Mind in Children With Autism Spectrum Disorder: A Randomized Clinical Trial

open access: yesAutism Research, EarlyView.
ABSTRACT To evaluate, in a post hoc subanalysis, the effects of cannabidiol (CBD)‐rich cannabis oil on facial expression recognition and theory of mind in children with autism spectrum disorder (ASD). This post hoc subanalysis included children from a double‐blind, randomized, placebo‐controlled trial who completed social cognition assessments at ...
Wandersonia Moreira Brito Medeiros   +12 more
wiley   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani   +4 more
wiley   +1 more source

Differential placebo effect of sham acupuncture for chronic pain: a network meta-analysis of randomized controlled trials. [PDF]

open access: yesBMC Complement Med Ther
Wan R   +11 more
europepmc   +1 more source

Open-label placebo: clinical efficacy, ethical implications and future perspectives

open access: yes
openIl placebo open label (OLP), ovvero la somministrazione consapevole di un trattamento inattivo, rappresenta una sfida innovativa e potenzialmente rivoluzionaria nell’ambito della medicina contemporanea.
DE PELLEGRIN, DANIELE
core  

Reply

open access: yes
Arthritis &Rheumatology, EarlyView.
Joseph F. Merola   +6 more
wiley   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Home - About - Disclaimer - Privacy